Neuroprotector (farmacología) (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Neuroprotector (farmacología)" in Spanish language version.

refsWebsite

Global rank Spanish rank

11doi.org

2^nd place

3clinicaltrials.gov

5,225^th place

9,066^th place

2nature.com

234^th place

123^rd place

1google.com.uy

3,367^th place

197^th place

1nih.gov

4^th place

1wiley.com

222^nd place

135^th place

clinicaltrials.gov

ClinicalTrials. «A Safety Study of LY2886721 Multiple Doses in Healthy Subjects». National Library of Medicine. Consultado el 5 de mayo de 2018.
ClinicalTrials (2017 (Actualización)). «An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738) (EPOCH)». National Library of Medicine. Consultado el 5 de mayo de 2018.
ClinicalTrials (Mayo 2017 (Actualización)). «A Drug-Drug Interaction Study of Lanabecestat (LY3314814) in Healthy Participants». National Library of Medicine.

doi.org

dx.doi.org

Walsh, Dominic M.; Teplow, David B. (2012). «Alzheimer's Disease and the Amyloid β-Protein». Progress in Molecular Biology and Translational Science (Elsevier Inc.) 107: 101. doi:10.1016/B978-0-12-385883-2.00012-6.
Shankar, Ganesh M; Li, Shaomin; Mehta, Tapan H; [Et al] (Junio de 2008). «Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory». Nature Medicine 14 (8): 837-842. doi:10.1038/nm1782.
Obregon, Demian; Hou, Huayan; Deng, Juan; [Et al] (Abril de 2012). «Soluble amyloid precursor protein-α modulates β-secretase activity and amyloid-β generation» (PDF (acceso público)). Nature Communications 3 (1). doi:10.1038/ncomms1781.
Ghosh, Arun K.; Gemma, Sandra; Tang, Jordan (Julio de 2008). «β-Secretase as a therapeutic target for Alzheimer’s disease». Neurotherapeutics 5 (3): 399-408. doi:10.1016/j.nurt.2008.05.007.
Chang, Wan-Pin; Koelsch, Gerald; Wong, Stephen; Downs, Deborah; Da, Huining; Weerasena, Vajira; Gordon, Brian; Devasamudram, Thippeswamy; Bilcer, Geoffrey; Ghosh, Arun K.; Tang, Jordan (Mayo de 2004). «In vivo inhibition of Aβ production by memapsin 2 (β-secretase) inhibitors». Journal of Neurochemistry 89 (6): 1409-1416. doi:10.1111/j.1471-4159.2004.02452.x.
Ghosh, Arun K.; Brindisi, Margherita; Tang, Jordan (Enero de 2012). «Developing β-secretase inhibitors for treatment of Alzheimer’s disease». Journal of Neurochemistry 120: 71-83. doi:10.1111/j.1471-4159.2011.07476.x.
Hussain, Ishrut; Hawkins, Julie; Harrison, David; [Et al] (Febrero de 2007). «Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases ?-cleavage of amyloid precursor protein and amyloid-? production in vivo». Journal of Neurochemistry 100 (3): 802-809. doi:10.1111/j.1471-4159.2006.04260.x.
Moussa, Charbel E-H. (Agosto de 2017). «Beta-secretase inhibitors in phase I and phase II clinical trials for Alzheimer’s disease». Expert Opinion on Investigational Drugs 26 (10): 1131-1136. doi:10.1080/13543784.2017.1369527.

doi.org

Walsh, Dominic M.; Teplow, David B. (2012). «Alzheimer's Disease and the Amyloid β-Protein». Progress in Molecular Biology and Translational Science (Elsevier Inc.) 107: 101. doi:10.1016/B978-0-12-385883-2.00012-6.
Hussain, Ishrut; Hawkins, Julie; Harrison, David; [Et al] (Febrero de 2007). «Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases ?-cleavage of amyloid precursor protein and amyloid-? production in vivo». Journal of Neurochemistry 100 (3): 802-809. doi:10.1111/j.1471-4159.2006.04260.x.
Moussa, Charbel E-H. (Agosto de 2017). «Beta-secretase inhibitors in phase I and phase II clinical trials for Alzheimer’s disease». Expert Opinion on Investigational Drugs 26 (10): 1131-1136. doi:10.1080/13543784.2017.1369527.

google.com.uy

books.google.com.uy

Stolerman, Ian P. (2010). Encyclopedia of psychopharmacology (Online-Ausg. edición). Berlin: Springer. p. 862. ISBN 978-3-540-68698-9. Consultado el 5 de mayo de 2018.

nature.com

Shankar, Ganesh M; Li, Shaomin; Mehta, Tapan H; [Et al] (Junio de 2008). «Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory». Nature Medicine 14 (8): 837-842. doi:10.1038/nm1782.
Obregon, Demian; Hou, Huayan; Deng, Juan; [Et al] (Abril de 2012). «Soluble amyloid precursor protein-α modulates β-secretase activity and amyloid-β generation» (PDF (acceso público)). Nature Communications 3 (1). doi:10.1038/ncomms1781.

nih.gov

ncbi.nlm.nih.gov

Mal'tsev, AV; Davidchenko, NV; Uteshev, VK; [Et al] (2013). «[Intensive protein synthesis in neurons and phosphorylation of beta-amyloid precursor protein and tau-protein are triggering factors of neuronal amyloidosis and Alzheimer's disease] (Abstract)». Biomeditsinskaia khimiia 59 (2): 144-70. PMID 23789343.

wiley.com

onlinelibrary.wiley.com

Chang, Wan-Pin; Koelsch, Gerald; Wong, Stephen; Downs, Deborah; Da, Huining; Weerasena, Vajira; Gordon, Brian; Devasamudram, Thippeswamy; Bilcer, Geoffrey; Ghosh, Arun K.; Tang, Jordan (Mayo de 2004). «In vivo inhibition of Aβ production by memapsin 2 (β-secretase) inhibitors». Journal of Neurochemistry 89 (6): 1409-1416. doi:10.1111/j.1471-4159.2004.02452.x.